BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 19764431)

  • 1. [Genetic polymorphisms and human sensitivity to pain and opioids].
    Nishizawa D; Nagashima M; Satoh Y; Tagami M; Ikeda K
    Masui; 2009 Sep; 58(9):1093-101. PubMed ID: 19764431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current evidence for a genetic modulation of the response to analgesics.
    Lötsch J; Geisslinger G
    Pain; 2006 Mar; 121(1-2):1-5. PubMed ID: 16472919
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of genetic factors on opioid action.
    Kosarac B; Fox AA; Collard CD
    Curr Opin Anaesthesiol; 2009 Aug; 22(4):476-82. PubMed ID: 19502975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics in pain management: the clinical need.
    Webster LR
    Clin Lab Med; 2008 Dec; 28(4):569-79. PubMed ID: 19059063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [How can we cope with wide individual variations in pain intensity and opioid requirements after surgery?].
    Hayashida M; Maruyama K
    Masui; 2009 Sep; 58(9):1086-92. PubMed ID: 19764430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic factors in pain and its treatment.
    Stamer UM; Stüber F
    Curr Opin Anaesthesiol; 2007 Oct; 20(5):478-84. PubMed ID: 17873601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Postoperative pain management following orthognathic surgery in consideration of individual differences--is the antinociceptive effect of fentanyl related to the genotype involving nucleotide at OPRM1?].
    Fukuda K; Hayashida M; Ikeda K
    Masui; 2009 Sep; 58(9):1102-8. PubMed ID: 19764432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genetic variation-- important for the clinical effect of opioids?].
    Klepstad P; Dale O; Borchgrevink PC; Kaasa S; Skorpen F
    Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2655-8. PubMed ID: 16215614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Individual differences in analgesic effects of narcotics].
    Ide S; Kasai S; Ikeda K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Feb; 28(1):43-8. PubMed ID: 18411709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between OPRM1 gene polymorphisms and fentanyl sensitivity in patients undergoing painful cosmetic surgery.
    Fukuda K; Hayashida M; Ide S; Saita N; Kokita Y; Kasai S; Nishizawa D; Ogai Y; Hasegawa J; Nagashima M; Tagami M; Komatsu H; Sora I; Koga H; Kaneko Y; Ikeda K
    Pain; 2009 Dec; 147(1-3):194-201. PubMed ID: 19783098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics in palliative care.
    Kleine-Brueggeney M; Musshoff F; Stuber F; Stamer UM
    Forensic Sci Int; 2010 Dec; 203(1-3):63-70. PubMed ID: 20709477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics of opioids.
    Somogyi AA; Barratt DT; Coller JK
    Clin Pharmacol Ther; 2007 Mar; 81(3):429-44. PubMed ID: 17339873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications of opioid pharmacogenetics.
    Argoff CE
    Clin J Pain; 2010 Jan; 26 Suppl 10():S16-20. PubMed ID: 20026961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pain polymorphisms and opioids: An evidence based review.
    Vieira CMP; Fragoso RM; Pereira D; Medeiros R
    Mol Med Rep; 2019 Mar; 19(3):1423-1434. PubMed ID: 30592275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between human opioid receptor genes polymorphisms and pressure pain sensitivity in females*.
    Huang CJ; Liu HF; Su NY; Hsu YW; Yang CH; Chen CC; Tsai PS
    Anaesthesia; 2008 Dec; 63(12):1288-95. PubMed ID: 19032295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the genetic determinants of pain and pain management.
    Miaskowski C
    Semin Oncol Nurs; 2009 May; 25(2 Suppl 1):S1-7. PubMed ID: 19447317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic polymorphisms and opioid therapies].
    Landau R
    Presse Med; 2008 Oct; 37(10):1415-22. PubMed ID: 18440763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can heterogeneity of chronic sickle-cell disease pain be explained by genomics? A literature review.
    Adegbola MA
    Biol Res Nurs; 2009 Jul; 11(1):81-97. PubMed ID: 19487302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of CYP2D6 and OPRM1 pharmacogenetic testing for opioid therapy.
    Reynolds KK; Ramey-Hartung B; Jortani SA
    Clin Lab Med; 2008 Dec; 28(4):581-98. PubMed ID: 19059064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pain and genetics.
    Fernandez Robles CR; Degnan M; Candiotti KA
    Curr Opin Anaesthesiol; 2012 Aug; 25(4):444-9. PubMed ID: 22732422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.